All charts and data below are with dividends reinvested. (Inflation adjustment is OFF !)
DNA total return snapshot: DNA returned −24.02% over the past year and +16.85% YTD, with dividends reinvested. Since Apr. 19, 2021, DNA is down −97.60% in nominal total return, or −49.19%/yr, and is currently −98.37% below its total-return high on Nov. 8, 2021.
Data ending Thu Oct. 22, 2026
| Mon 2021-04-19💬 to Thu 2026-10-22 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| DNA × |
−97.60%
−49.19%/yr |
−56.57%/yr
R2=0.892 |
||||
| Ginkgo Bioworks Holdings NYSE Common Stock | ||||||
| Mon 2021-04-19💬 to Thu 2026-10-22 |
Start
Value |
End
Value |
|---|---|---|
| DNA × |
$10,000.00
2021-04-19 |
$239.87
2026-10-22 |
| YTD | YoY | |
|---|---|---|
| DNA × | +16.85% | −24.02% |
|
Current
Drawdown |
Worst
Drawdown |
|
|---|---|---|
| DNA × |
−98.37%
on 2026-10-22 from 2021-11-08 peak |
−99.10%
on 2024-09-09 from 2021-11-08 peak |
| Period ending Thu 2026-10-22 | 1 yr | 2 yr | 3 yr | 5 yr | 10 yr |
|---|---|---|---|---|---|
| DNA × | −24.02% |
+3.52% +1.74%/yr |
−84.54% −46.33%/yr |
−98.15% −54.99%/yr |
— |
| Year | DNA |
|---|---|
| 2026 (YTD) | +16.85% |
| 2025 | −15.38% |
| 2024 | −85.47% |
| 2023 | +0.00% |
| 2022 | −79.66% |
| 2021 | −17.89% |